Malarone treatment failure not associated with previously described mutations in the cytochrome b gene
<p>Abstract</p> <p>Malarone<sup>® </sup>(atovaquone-proguanil) is an effective drug for the treatment and prophylaxis of multidrug-resistant falciparum malaria. However, first cases of resistance have been reported, which are associated with mutations at codon 268 of th...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2004-06-01
|
| Series: | Malaria Journal |
| Online Access: | http://www.malariajournal.com/content/3/1/14 |